Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CAMBRIDGE, Mass., June 6, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases, today announced that on June 3, 2013, Aegerion granted stock options to purchase an aggregate of 8,000 shares of common stock to two new employees under the inducement stock option program described below. Each stock option has an exercise price per share equal to $73.39, the closing price of Aegerion’s common stock on the grant date; vests in equal monthly installments over four years; has a ten year term; and is subject to the terms and conditions of Aegerion’s Inducement Award Stock Option Plan, and the terms and conditions of a stock option agreement covering the grant.
Help employers find you! Check out all the jobs and post your resume.
